Page 2 - Jessica Serra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jessica serra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jessica Serra Today - Breaking & Trending Today

Revance Provides Corporate Update at Investor Day

Revance Provides Corporate Update at Investor Day
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sara Fahy , Laurence Watts , Jessica Serra , Revance Therapeutics Inc , Securities Exchange , Gilmartin Group , Exchange Commission , Allergan Inc , Viatris Inc , Investor Day , Revance Aesthetics , Revance Therapeutics , Athyrium Capital , Investor Relations , Shanghai Fosun Pharmaceutical , Resilient Hyaluronic Acid , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act ,

Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update

- Q2 total revenue of $58.1 million, a YoY increase of 104.9%.- Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%.- Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of 47.1%.- Bolstered financial position with $100 million net proceeds from ATM program and $50 million in notes available to be. ....

United States , Jessica Serra , Fosun Pharma , Laurence Watts , Markj Foley , China National Medical Products Administration , Securities Exchange , Gilmartin Group , Viatris Inc , Revance Therapeutics Inc , Hint Inc , Drug Administration , Exchange Commission , Athyrium Capital , Revance Therapeutics , Note Purchase Agreement , Second Tranche , Third Tranche , Chief Executive Officer , Investor Day , Quarter Highlights , Relational Commerce , National Medical Products Administration , Hyaluronic Acid , Private Securities Litigation Reform Act , Securities Act ,

Revance to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Revance to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Laurence Watts , Saraj Fahy , Jessica Serra , Viatris Inc , Gilmartin Group , Revance Therapeutics Inc , Call Scheduled , Relational Commerce , Revance Therapeutics , Hyaluronic Acid ,

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. ....

Phil Vickers , Jamie Krause , Piper Sandler , Jessica Serra , David Amsellem , Mark Foley , Dustin Sjuts , Toby Schilke , Justin Ford , Nashville Experience Center , Ajinomoto Biopharma Services , National Cancer Institute On Unsplash , Revance Therapeutics Inc , Health Photo , Services Segment , Revance Therapeutics , Call Transcript February , Revance Therapeutics Fourth Quarter , Full Year , Corporate Update Conference , Investor Relations , Chief Executive Officer , Chief Financial Officer , Risk Factors , Annual Report , Vlad Coric ,

Revance Therapeutics (RVNC) Appoints Vlad Coric to its Board

Revance Therapeutics (RVNC) Appoints Vlad Coric to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Phil Vickers , Markj Foley , Jessica Serra , Laurence Watts , Philip Vickers , Sara Fahy , Bristol Myers Squibb , Bristol Myers Squibb Company , Avita Therapeutics Inc , Wake Forest University School Of Medicine , University Of Connecticut , Oncology Global Clinical Research , Revance Therapeutics Inc , Hint Inc , Veradermics Inc , Capital Suvretta Holdings Corp , Yale School Of Medicine , Pyramid Biosciences Inc , Exchange Commission , Gilmartin Group , Securities Exchange , Neuroscience Global Clinical Research , Viatris Inc , Vlad Coric , Yale School ,